JMP Securities Initiates Coverage On OptimizeRx With Market Outperform Rating, Announces Price Target of $15
JMP Securities Initiates Coverage On OptimizeRx With Market Outperform Rating, Announces Price Target of $15
JMP證券以市場跑贏大盤評級啓動對OptimizerX的報道，宣佈目標股價爲15美元
JMP Securities analyst Constantine Davides initiates coverage on OptimizeRx (NASDAQ:OPRX) with a Market Outperform rating and announces Price Target of $15.
JMP證券分析師康斯坦丁·戴維斯以市場跑贏大盤的評級開始對OptimizerX（納斯達克股票代碼：OPRX）進行報道，並宣佈目標股價爲15美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。